House Memorial 58 requests the New Mexico Department of Health to conduct a comprehensive study on psilocybin-based medication treatment, recognizing the growing interest in its therapeutic potential for mental health conditions such as depression, anxiety, and PTSD. The study aims to explore various aspects of psilocybin treatment, including the standardization of training for medical professionals, the establishment of testing protocols for product safety and consistency, and the review of existing legal and regulatory barriers. Additionally, it will assess public health concerns, economic equity impacts, and engage stakeholders for input on policy recommendations.

The memorial emphasizes the need for a structured approach to psilocybin treatment, including potential frameworks for licensing and oversight, and calls for the Department of Health to submit a detailed report on its findings and recommendations. This report should include proposed regulatory changes, pilot programs, and public health safeguards to ensure safe and effective access to psilocybin-based treatments for New Mexico residents.